Chemotherapy enhances oncolytic recombinant poliovirus efficacy
Publication
, Conference
Bryant, J; Brown, M; Gromeier, M
Published in: JOURNAL FOR IMMUNOTHERAPY OF CANCER
November 7, 2017
Duke Scholars
Published In
JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN
2051-1426
Publication Date
November 7, 2017
Volume
5
Publisher
BMC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bryant, J., Brown, M., & Gromeier, M. (2017). Chemotherapy enhances oncolytic recombinant poliovirus efficacy. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 5). BMC.
Bryant, Jeffrey, Michael Brown, and Matthias Gromeier. “Chemotherapy enhances oncolytic recombinant poliovirus efficacy.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 5. BMC, 2017.
Bryant J, Brown M, Gromeier M. Chemotherapy enhances oncolytic recombinant poliovirus efficacy. In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2017.
Bryant, Jeffrey, et al. “Chemotherapy enhances oncolytic recombinant poliovirus efficacy.” JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 5, BMC, 2017.
Bryant J, Brown M, Gromeier M. Chemotherapy enhances oncolytic recombinant poliovirus efficacy. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2017.
Published In
JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN
2051-1426
Publication Date
November 7, 2017
Volume
5
Publisher
BMC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology